Perspective Therapeutics (CATX) Institutional Ownership

$2.78 -0.06 (-1.94%)

Closing price 02/21/2025 03:59 PM Eastern

Extended Trading

$2.84 +0.06 (+2.15%)

As of 02/21/2025 06:33 PM Eastern

Compare

Current Institutional Ownership Percentage: 54.66%
Number of Institutional Buyers (last 12 months): 84
Total Institutional Inflows (last 12 months): $177.57M

Number of Institutional Sellers (last 12 months): 29
Total Institutional Outflows (last 12 months): $666.11M

Get CATX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CATX Institutional Buying and Selling by Quarter

Perspective Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	70,150	$224K	0.0%	+19.6%	0.104%
2/17/2025	Velan Capital Investment Management LP	500,000	$1.60M	1.4%	N/A	0.740%
2/17/2025	Squarepoint Ops LLC	196,208	$626K	0.0%	N/A	0.290%
2/17/2025	Wexford Capital LP	20,000	$64K	0.0%	N/A	0.030%
2/17/2025	Two Sigma Advisers LP	151,610	$484K	0.0%	N/A	0.224%
2/17/2025	Two Sigma Investments LP	650,351	$2.08M	0.0%	N/A	0.962%
2/17/2025	Sherbrooke Park Advisers LLC	21,564	$69K	0.0%	N/A	0.032%
2/17/2025	Sphera Funds Management LTD.	460,247	$1.47M	0.3%	-21.9%	0.681%
2/17/2025	Point72 Asset Management L.P.	54,893	$175K	0.0%	N/A	0.081%
2/17/2025	ProShare Advisors LLC	15,225	$49K	0.0%	+49.1%	0.023%
Get the Latest News and Ratings for CATX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Perspective Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
2/17/2025	Nuveen Asset Management LLC	722,048	$2.30M	0.0%	-13.0%	1.068%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	123,243	$393K	0.0%	+73.8%	0.182%
2/17/2025	Octagon Capital Advisors LP	2,304,752	$7.35M	1.2%	+62.1%	3.410%
2/17/2025	Millennium Management LLC	1,295,343	$4.13M	0.0%	N/A	1.916%
2/17/2025	Janus Henderson Group PLC	17,839	$57K	0.0%	-99.6%	0.026%
2/17/2025	Deutsche Bank AG	46,579	$149K	0.0%	+76.0%	0.069%
2/17/2025	DAFNA Capital Management LLC	130,169	$415K	0.1%	-43.5%	0.193%
2/17/2025	Deerfield Management Company L.P. Series C	2,938,754	$9.38M	0.2%	+4.3%	4.348%
2/17/2025	Corton Capital Inc.	19,180	$61K	0.0%	N/A	0.028%
2/17/2025	Cubist Systematic Strategies LLC	261,474	$834K	0.0%	N/A	0.387%
2/17/2025	Balyasny Asset Management L.P.	130,914	$418K	0.0%	N/A	0.194%
2/17/2025	Bank of America Corp DE	48,777	$156K	0.0%	-72.0%	0.072%
2/17/2025	BNP Paribas Financial Markets	51,094	$163K	0.0%	+7.4%	0.076%
2/17/2025	Ameriprise Financial Inc.	17,326	$55K	0.0%	-97.4%	0.026%
2/14/2025	Mercer Global Advisors Inc. ADV	16,088	$51K	0.0%	N/A	0.024%
2/14/2025	Freestone Grove Partners LP	47,386	$151K	0.0%	N/A	0.070%
2/14/2025	Schonfeld Strategic Advisors LLC	168,500	$538K	0.0%	-71.5%	0.249%
2/14/2025	Northern Trust Corp	487,273	$1.55M	0.0%	+2.8%	0.721%
2/14/2025	Tudor Investment Corp ET AL	28,577	$91K	0.0%	N/A	0.042%
2/14/2025	Aquatic Capital Management LLC	32,718	$104K	0.0%	N/A	0.048%
2/14/2025	Virtus ETF Advisers LLC	20,487	$65K	0.0%	+157.9%	0.030%
2/14/2025	Nebula Research & Development LLC	21,850	$70K	0.0%	+47.2%	0.032%
2/14/2025	Rock Springs Capital Management LP	444,383	$1.42M	0.1%	+7.2%	0.657%
2/14/2025	MetLife Investment Management LLC	22,228	$71K	0.0%	-28.7%	0.033%
2/14/2025	Altium Capital Management LLC	92,224	$294K	0.1%	-68.2%	0.136%
2/13/2025	Marshall Wace LLP	807,172	$2.58M	0.0%	-45.9%	1.194%
2/13/2025	Affinity Asset Advisors LLC	1,300,000	$4.15M	0.6%	+160.0%	1.923%
2/13/2025	Jump Financial LLC	215,725	$688K	0.0%	N/A	0.319%
2/13/2025	Walleye Capital LLC	475,792	$1.52M	0.0%	+2,526.2%	0.704%
2/13/2025	XTX Topco Ltd	18,070	$58K	0.0%	-51.6%	0.027%
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…
2/13/2025	Mariner LLC	46,900	$150K	0.0%	N/A	0.069%
2/13/2025	Barclays PLC	94,879	$302K	0.0%	-16.8%	0.140%
2/13/2025	Legal & General Group Plc	48,538	$155K	0.0%	-13.5%	0.072%
2/13/2025	Aristides Capital LLC	58,700	$187K	0.0%	N/A	0.087%
2/13/2025	Wells Fargo & Company MN	26,462	$84K	0.0%	+45.7%	0.039%
2/12/2025	National Bank of Canada FI	11,000	$35K	0.0%	+549,900.0%	0.016%
2/12/2025	Arrowstreet Capital Limited Partnership	36,752	$117K	0.0%	-64.1%	0.054%
2/12/2025	JPMorgan Chase & Co.	149,045	$475K	0.0%	+498.3%	0.221%
2/11/2025	KLP Kapitalforvaltning AS	24,769	$79K	0.0%	N/A	0.037%
2/10/2025	Swiss National Bank	86,260	$275K	0.0%	-6.4%	0.128%
2/7/2025	HighTower Advisors LLC	178,111	$568K	0.0%	+26.1%	0.264%
2/7/2025	Citizens Financial Group Inc. RI	50,000	$160K	0.0%	N/A	0.074%
2/7/2025	AMG National Trust Bank	29,980	$92K	0.0%	-19.7%	0.044%
2/6/2025	Aigen Investment Management LP	10,522	$34K	0.0%	N/A	0.016%
2/6/2025	Charles Schwab Investment Management Inc.	406,966	$1.30M	0.0%	-6.1%	0.602%
2/4/2025	Bank of New York Mellon Corp	143,469	$458K	0.0%	+3.4%	0.212%
2/4/2025	Y Intercept Hong Kong Ltd	10,263	$33K	0.0%	N/A	0.015%
2/3/2025	Nicholson Wealth Management Group LLC	1,609,283	$5.13M	3.4%	+0.4%	2.381%
1/30/2025	WealthPlan Investment Management LLC	401,049	$1.28M	0.1%	+18.2%	0.593%
1/30/2025	Rhumbline Advisers	94,992	$303K	0.0%	+4.5%	0.141%
1/30/2025	Vontobel Holding Ltd.	16,000	$51K	0.0%	N/A	0.024%
1/23/2025	Koa Wealth Management LLC	25,975	$83K	0.1%	N/A	0.038%
1/22/2025	Wealth Effects LLC	38,000	$121K	0.0%	+186.8%	0.056%
1/17/2025	SG Americas Securities LLC	26,088	$83K	0.0%	+41.3%	0.039%
1/16/2025	Trueblood Wealth Management LLC	22,236	$71K	0.0%	+37.0%	0.033%
1/15/2025	Taylor & Morgan Wealth Management LLC	56,000	$179K	0.1%	+86.7%	0.083%
12/26/2024	JPMorgan Chase & Co.	24,912	$333K	0.0%	+24.1%	0.037%
11/19/2024	Barclays PLC	114,075	$1.52M	0.0%	+587.9%	0.169%
11/18/2024	JDM Financial Group LLC	3,500	$47K	0.0%	-90.0%	0.005%
11/16/2024	Geode Capital Management LLC	1,164,204	$15.55M	0.0%	+12.5%	1.722%
11/15/2024	Barclays PLC	114,075	$1.52M	0.0%	+587.9%	0.169%
11/15/2024	XTX Topco Ltd	37,300	$498K	0.0%	N/A	0.055%
11/15/2024	Jane Street Group LLC	25,256	$337K	0.0%	-67.9%	0.037%
11/15/2024	Sphera Funds Management LTD.	589,295	$7.87M	1.3%	-25.1%	0.872%
11/15/2024	State Street Corp	2,190,239	$29.24M	0.0%	+119.6%	3.240%
11/15/2024	Janus Henderson Group PLC	4,799,352	$64.01M	0.0%	+8.0%	7.101%
11/15/2024	HighVista Strategies LLC	138,350	$1.85M	0.6%	+21.8%	0.205%
11/14/2024	Verition Fund Management LLC	28,723	$383K	0.0%	N/A	0.043%
11/14/2024	Walleye Capital LLC	18,117	$242K	0.0%	-96.5%	0.027%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	58,678	$783K	0.0%	+5.8%	0.087%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,378	$152K	0.0%	N/A	0.017%
11/14/2024	Ally Bridge Group NY LLC	341,739	$4.56M	2.4%	-13.8%	0.507%
11/14/2024	MetLife Investment Management LLC	31,165	$416K	0.0%	+159.1%	0.046%
11/13/2024	BNP Paribas Financial Markets	47,565	$635K	0.0%	+1,302.7%	0.071%
11/13/2024	FMR LLC	5,504,822	$73.49M	0.0%	+3,994.9%	8.164%
11/13/2024	The Manufacturers Life Insurance Company	20,514	$274K	0.0%	+8.9%	0.030%
11/12/2024	Eagle Asset Management Inc.	181,467	$2.42M	0.0%	-24.9%	0.269%
11/12/2024	Charles Schwab Investment Management Inc.	433,522	$5.79M	0.0%	+221.7%	0.643%
11/9/2024	Intech Investment Management LLC	10,289	$137K	0.0%	N/A	0.015%
11/7/2024	LMR Partners LLP	30,000	$400K	0.0%	N/A	0.044%
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here.
11/6/2024	RIA Advisory Group LLC	25,620	$342K	0.1%	N/A	0.038%
11/6/2024	CIBC Asset Management Inc	19,415	$259K	0.0%	N/A	0.029%
11/5/2024	Victory Capital Management Inc.	50,460	$674K	0.0%	+328.7%	0.075%
11/5/2024	WealthPlan Investment Management LLC	339,292	$4.53M	0.5%	N/A	0.503%
11/4/2024	Los Angeles Capital Management LLC	11,424	$153K	0.0%	N/A	0.017%
10/30/2024	AlphaCentric Advisors LLC	80,000	$1.07M	0.8%	-2.4%	0.128%
10/28/2024	Hills Bank & Trust Co	1,027,830	$13.72M	1.0%	N/A	1.651%
10/28/2024	US Bancorp DE	6,576	$88K	0.0%	+142.7%	0.011%
10/24/2024	Taylor & Morgan Wealth Management LLC	30,000	$400K	0.3%	N/A	0.048%
10/23/2024	Trueblood Wealth Management LLC	16,236	$217K	0.1%	N/A	0.026%

(Data available from 1/1/2016 forward)

CATX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CATX shares?: During the previous two years, 103 institutional investors and hedge funds held shares of Perspective Therapeutics. The most heavily invested institutionals were FMR LLC ($73.49M), State Street Corp ($29.24M), Vanguard Group Inc. ($21.16M), Geode Capital Management LLC ($15.55M), Hills Bank & Trust Co ($13.72M), Deerfield Management Company L.P. Series C ($9.38M), and Octagon Capital Advisors LP ($7.35M).Learn more on CATX's institutional investors.
What percentage of Perspective Therapeutics stock is owned by institutional investors?: 54.66% of Perspective Therapeutics stock is owned by institutional investors. Learn more on CATX's institutional investor holdings.
Which institutional investors have been buying Perspective Therapeutics stock?: Of the 85 institutional investors that purchased Perspective Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($13.45M), Affinity Asset Advisors LLC ($5.90M), FMR LLC ($5.37M), Vanguard Group Inc. ($4.57M), Perkins Capital Management Inc. ($2.67M), Nicholson Wealth Management Group LLC ($1.61M), and Millennium Management LLC ($1.30M).

How much institutional buying is happening at Perspective Therapeutics?: Institutional investors have bought a total of 46,390,536 shares in the last 24 months. This purchase volume represents approximately $177.57M in transactions.
Which Perspective Therapeutics major shareholders have been selling company stock?: Of the 30 institutional investors that sold Perspective Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($25.36M), Marshall Wace LLP ($18.37M), Point72 Asset Management L.P. ($13.25M), Baker BROS. Advisors LP ($7.49M), Janus Henderson Group PLC ($4.78M), Affinity Asset Advisors LLC ($4.55M), and Perkins Capital Management Inc. ($1.97M).
How much institutional selling is happening at Perspective Therapeutics?: Institutional investors have sold a total of 80,971,266 shares in the last 24 months. This volume of shares sold represents approximately $666.11M in transactions.

Related Companies

This page (NYSE:CATX) was last updated on 2/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Perspective Therapeutics (CATX) Institutional Ownership

CATX Institutional Buying and Selling by Quarter

Perspective Therapeutics Major Shareholders & Ownership History

CATX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Perspective Therapeutics (CATX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSE:CATX)

CATX Institutional Buying and Selling by Quarter

Perspective Therapeutics Major Shareholders & Ownership History

CATX Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools